Decorin is down‐regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF‐induced myeloma plasma cell viability and migration
- 23 April 2013
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 91 (3) , 196-200
Abstract
Objectives: Decorin is a stromal‐produced small leucine‐rich proteoglycan known to attenuate tumour pro‐survival, migration, proliferation and angiogenic signalling pathways. Recent studies have shown that decorin interacts with the hepatocyte growth factor (HGF) receptor c‐Met, a potential key pathway in multiple myeloma (MM).Methods: Decorin levels in paired peripheral blood and bone marrow plasma samples from healthy volunteers (HV) (n = 23), and patients with monoclonal gammopathy of undetermined significance (MGUS) (n = 41) and MM (n = 19) were determined by ELISA. Further, the ability of decorin to inhibit HGF‐induced effects on MM cell lines were analysed in vitro using cell viability and Transwell migration assays.Results: We found that decorin concentrations were significantly higher (P < 0.05) in bone marrow (BM) plasma from HVs (median 35.2 ng/mL; range, 15.3–99.1) compared with MGUS (median 22.5 ng/mL; range, 11.1–59.5) and patients with MM (median 21.5 ng/mL; range, 10.6–35.9). Decorin levels were higher in BM plasma than in peripheral blood in all groups, with a BM/PB ratio of 3.9, 3.4 and 2.5 for HV, MGUS and MM, respectively. A positive correlation (Spearman's ρ = 0.51, P < 0.05) was found between simultaneously measured levels of HGF and decorin in BM plasma in HVs, but not in MGUS or MM samples. Functionally, decorin inhibited HGF‐induced migration and viability of INA‐6 and ANBL‐6 MM cell lines, independent of c‐Met down‐regulation.Conclusion: Our results show that decorin is down‐regulated in MGUS and MM bone marrow plasma and that it inhibits HGF‐induced viability and migration of myeloma cell lines in vitro.Keywords
This publication has 13 references indexed in Scilit:
- Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in miceCarcinogenesis, 2011
- Decorin Antagonizes IGF Receptor I (IGF-IR) Function by Interfering with IGF-IR Activity and Attenuating Downstream SignalingJournal of Biological Chemistry, 2011
- Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous BonePLOS ONE, 2010
- Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacityJournal of Bone and Mineral Research, 2010
- Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone diseaseExperimental Hematology, 2010
- Decorin is a novel antagonistic ligand of the Met receptorJournal of Cell Biology, 2009
- Tumor microenvironment: Modulation by decorin and related molecules harboring leucine‐rich tandem motifsInternational Journal of Cancer, 2008
- Role of decorin in the antimyeloma effects of osteoblastsBlood, 2008
- HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myelomaBlood, 2006
- Decorin prevents metastatic spreading of breast cancerOncogene, 2004